Pereyra-Rodriguez José Juan, Galán Gutiérrez Manuel, Armario-Hita José Carlos, Ruiz-Villaverde Ricardo
Department of Dermatology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Department of Dermatology, Hospital Universitario Reina Sofía, Córdoba, Spain.
Dermatol Ther. 2020 Nov;33(6):e13866. doi: 10.1111/dth.13866. Epub 2020 Jul 8.
Chronic urticaria (CU) has a devastating effect on the quality of life of patients who suffer from it. The objective of this study is to determine the prevalence of severe chronic spontaneous urticaria (CSU) in adults in eight health areas in Andalucía. A retrospective observational study from January 2019 to December 2019 was conducted with the participation of seven reference hospitals that were analyzed, including a total reference population of 3 159 001 individuals ≥18 years. The analysis was carried out on the characteristics of the population and the estimated prevalence. In total, 369 patients with a diagnosis of CSU refractory to antagonist of histamine were registered. We have found a prevalence of refractory patients of 0.0012% (95% CI 0.0010%-0.0013), ranging from 0.006% to 0.02%. The present study has helped to describe the prevalence and characteristics of patients with severe urticarial. The prevalence is lower than previously reported. We have observed differences between hospital areas. There will be a new line of research at the national level to help improve the identification of patients with CSU.
慢性荨麻疹(CU)对患有该病的患者的生活质量具有毁灭性影响。本研究的目的是确定安达卢西亚八个健康区域中成人严重慢性自发性荨麻疹(CSU)的患病率。2019年1月至2019年12月进行了一项回顾性观察研究,有七家参考医院参与并进行了分析,包括3159001名年龄≥18岁的总参考人群。对人群特征和估计患病率进行了分析。总共登记了369例对组胺拮抗剂难治的CSU诊断患者。我们发现难治性患者的患病率为0.0012%(95%可信区间0.0010%-0.0013%),范围在0.006%至0.02%之间。本研究有助于描述严重荨麻疹患者的患病率和特征。患病率低于先前报道。我们观察到医院区域之间存在差异。将在国家层面开展新的研究系列,以帮助改善CSU患者的识别。